Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

The biotech's candidate may treat a great number of illnesses that have one thing in common.

The biggest payoff from investing in stocks often comes years down the road, when companies you've invested in have grown ...

We'll know more about the company's medium-term prospects by the end of the year.

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $50.71, marking a -2.59% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.04%.

Most asset managers try to track the market. Through ARK Investment, Cathie Wood is trying to get ahead of the market’s best ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $55.72, moving -1.83% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.26%. On ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its ...

A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...